menu

QuintilesIMS Blog

Fresh ideas and insights from our experts around the globe

intersection
Science and technology are constantly evolving, enabling researchers to capture more and better data across the drug development lifecycle. But lagging regulations may prevent us from making the most of these new tools.
Karen Knecht
Helping to move the healthcare system from volume-based to value-based.
Read More
Jon Morris
Amazing innovations amidst the turmoil in Washington make this healthcare IT tech conference one that should not to be missed.
Read More
Ashish Jain
Why biopharma companies are bringing patients into early phase trials, and how they overcome the obstacles.
Read More
RobinHuff
The European Medicines Agency clarifies key concepts on orphan drug designation and marketing authorization — which may provide greater predictability for drug developers.
Read More
Avi Kulkarni
Insights from this year’s West Coast Executive Vision Forum program.
Read More
Peter Rutherford
As cancer care becomes more complex, oncologists need support to enable them to choose the right medications and pass the information on to patients and their carers.
Read More
Brad Smith
A look at the trends that are shaping the future of oncology research.
Read More
Kimberly Ray
Why targeted oncology research requires a more precise approach to clinical trial design.
Read More
John Doyle
Peter Rutherford
Biopharma need to remember the patient – the “end user” – when developing materials, education and support mechanisms that accompany treatments.
Read More